PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Impressive, especially considering that the study was not...

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Impressive, especially considering that the study was not powered to achieve statistical significance. 008 and the canine study just adds to the mounting evidence that iPPS will one day be approved for treatment for OA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.